Half-lives of APC/C substrates
| Substrate | Parameter | Control siRNA | siMAD2L2 | siMAD2L2:hMAD2L2-myc |
| Cyclin B1 | T1/2 | 31.7 ± 0.9 | 29.6 ± 0.01 | 44.3 ± 1.5 |
| Cyclin B1 | R2 | 0.947 | 0.999 | 0.932 |
| Securin | T1/2 | 30 ± 0.9 | 29.1 ± 0.50 | 26.8 ± 0.2 |
| Securin | R2 | 0.938 | 0.965 | 0.982 |
| CDC20 | T1/2 | 50.6 ± 0.6 | 38.1 ± 0.8 | 49.2 ± 1.3 |
| CDC20 | R2 | 0.975 | 0.958 | 0.950 |
| AURKA | T1/2 | 77.0 ± 6.4 | 46.5 ± 2.1 | 85.2 ± 3.8 |
| AURKA | R2 | 0.842 | 0.913 | 0.914 |
| UBCH10 | T1/2 | 106 ± 1.8 | 91.4 ± 5.8 | 105 ± 0.9 |
| UBCH10 | R2 | 0.967 | 0.876 | 0.983 |
| MAD2L2 | T1/2 | 51 ± 0.4 | – | 108 ± 5.3 |
| MAD2L2 | R2 | 0.983 | – | 0.904 |
| Substrate | Parameter | Control siRNA | siMAD2L2 | siMAD2L2:hMAD2L2-myc |
| Cyclin B1 | T1/2 | 31.7 ± 0.9 | 29.6 ± 0.01 | 44.3 ± 1.5 |
| Cyclin B1 | R2 | 0.947 | 0.999 | 0.932 |
| Securin | T1/2 | 30 ± 0.9 | 29.1 ± 0.50 | 26.8 ± 0.2 |
| Securin | R2 | 0.938 | 0.965 | 0.982 |
| CDC20 | T1/2 | 50.6 ± 0.6 | 38.1 ± 0.8 | 49.2 ± 1.3 |
| CDC20 | R2 | 0.975 | 0.958 | 0.950 |
| AURKA | T1/2 | 77.0 ± 6.4 | 46.5 ± 2.1 | 85.2 ± 3.8 |
| AURKA | R2 | 0.842 | 0.913 | 0.914 |
| UBCH10 | T1/2 | 106 ± 1.8 | 91.4 ± 5.8 | 105 ± 0.9 |
| UBCH10 | R2 | 0.967 | 0.876 | 0.983 |
| MAD2L2 | T1/2 | 51 ± 0.4 | – | 108 ± 5.3 |
| MAD2L2 | R2 | 0.983 | – | 0.904 |
Calculated from fitted exponential decay curves (Fig. 2 E).